Neoplasms - Therapy
Research News and Information

Saturday, November 21, 2009

Inclusion of parents in pediatric subspecialty team rounds: attitudes of the family and medical team.

30 Oct 2009 The importance of the family's involvement in caring for children with cancer is as tremendous as the need to successfully educate our medical students and residents about the value of effective communication and family-centered care. This article ... Read more...

NFAT proteins: emerging roles in cancer progression.

30 Oct 2009 The roles of nuclear factor of activated T cells (NFAT) transcription factors have been extensively studied in the immune system. However, ubiquitous expression of NFAT isoforms in mammalian tissues has recently been observed, and a role for these ... Read more...

Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador.

30 Oct 2009 Abandonment of therapy is one of the most common causes of treatment failure among children with cancer in low-income countries. Our objectives were to describe the prevalence and predictors of abandonment among such children with cancer in El ... Read more...

Latest indexed articles for 'Neoplasms - Therapy'

These are the very latest articles for this heading:

• The Canadian Triage Acuity Scale and oncological emergencies in the emergency department: the puzzle pieces may not fit. 29 Nov 2009
• Inclusion of parents in pediatric subspecialty team rounds: attitudes of the family and medical team. 30 Oct 2009
• NFAT proteins: emerging roles in cancer progression. 30 Oct 2009
• Computerized utility assessment for cancer decision making: promises and pitfalls. 30 Oct 2009
• Prevalence and predictors of abandonment of therapy among children with cancer in El Salvador. 30 Oct 2009
• ER-Golgi network--a future target for anti-cancer therapy. 30 Oct 2009
• Second primary cancers in survivors of childhood cancer. 29 Oct 2009
• [Oncolytic virus therapy using vesicular stomatitis virus] 19 Oct 2009
• "MIATA"-minimal information about T cell assays. 14 Oct 2009
• In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy. 13 Oct 2009
• No way out for tumor cells. 4 Oct 2009
• The First Children's Cancer Hospital, Egypt International Scientific Conference. 29 Sep 2009
• Shifting paradigms: the seeds of oncogene addiction. 29 Sep 2009
• Attacking cancer at its foundation. 29 Sep 2009
• Proposed FDA rules on painkillers in U.S. Rile cancer community. 29 Sep 2009
• Antifungal prophylaxis with micafungin in patients treated for childhood cancer. 29 Sep 2009
• Complementary and alternative medical therapies used by children with cancer treated at an Italian pediatric oncology unit. 29 Sep 2009
• GPs are to refer suspected cancer patients for tests in a week under new scheme. 27 Sep 2009
• mir-210: a sensor for hypoxic stress during tumorigenesis. 22 Sep 2009
• [Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review] 19 Sep 2009

See a longer list of these articles.

Technical information about 'Neoplasms'

Definition: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor UI: D009369

Alternative terms: Neoplasms; Neoplasm; Tumors; Tumor; Benign Neoplasms; Neoplasms, Benign; Benign Neoplasm; Neoplasm, Benign; Cancer; Cancers;

Related Mesh Headings: Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Carcinogens; DNA, Neoplasm; Oncogenic Viruses; Precancerous Conditions; RNA, Neoplasm; Pleural Effusion, Malignant; Genes, Tumor Suppressor; Anticarcinogenic Agents;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04;

Online Note: pre-explosion = NEOPLASMS (PX)

History Note: /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977

Technical Notes: avoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING (see note there) but "grading" = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.6+ or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS & its specifics; /genet: consider also GENES, TUMOR SUPPRESSOR /immunol: consider also TUMOR ESCAPE; consider also ANTIGENS, NEOPLASM & ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /nurs = the patient, ONCOLOGIC NURSING = the oncologic specialty; /prev: consider also ANTICARCINOGENIC AGENTS; /radiother = the patient, RADIATION ONCOLOGY = the specialty; consider also BRACHYTHERAPY; /second = NEOPLASM METASTASIS but do not confuse with NEOPLASMS, SECOND PRIMARY; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; Tumor Key: TN Suppl